State to negotiate medicine pricing agreement with pharma firms
Discussions with the industry body IPHA are already underway, with formal negotiations expected to kick off next month.
The Department of Public Expenditure and Reform (DPER) will be centrally involved in the negotiation of a new medicine pricing agreement with the Irish Pharmaceutical Healthcare Association (IPHA).
Discussions with the industry body are already underway, with formal negotiations expected to kick off next month.
A spokesman for health minister Leo Varadkar said that the state was using a “coordinated approach” involving the Department of Health, the HSE, the Department of Public Expenditure and Reform,...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Willie O’Reilly: Media commission can’t be just a worthy talking shop
With people increasingly unwilling to pay their TV licence fee and more inclined to put their money into streaming services, the Commission on the Future of Media needs to identify a way forward
Comment: Domestic law makers far better placed than CETA’s investment courts to judge policy choices
Contracting states, not corporations, must decide whether a violation is sufficiently significant to merit a complaint
Susan O’Keeffe: Public wants clarity, not false promises, from government
Stephen Donnelly may be pledging more than he can deliver on vaccines while the new Living with Covid plan is short on detail and has brought more confusion. We deserve better
Analysis: Variants and vaccines make projecting path of virus more complex
While the vaccine rollout should reduce the number of new Covid-19 cases, the increased transmissibility of the new variant mean progress in suppressing the virus has slowed
